
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (08): 997-1007.DOI: 10.12114/j.issn.1007-9572.2022.0535
Special Issue: 运动相关研究最新文章合辑; 神经系统疾病最新文章合辑; 脑健康最新研究合辑
• Evidence-based Medicine • Previous Articles Next Articles
Received:2022-03-23
Revised:2022-09-10
Published:2023-03-15
Online:2022-11-24
Contact:
TAN Jie, ZHAO Ning
通讯作者:
谭洁, 赵宁
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0535
| 步骤 | 检索式 |
|---|---|
| #1 | Transcranial Magnetic Stimulation[MeSH Terms] |
| #2 | Repetitive Transcranial Magnetic Stimulation* OR theta burst stimulation OR TMS OR TBS |
| #3 | #1 OR #2 |
| #4 | Stroke[MeSH Terms] |
| #5 | Cerebrovascular Accident OR Cerebrovascular Apoplexy OR Brain Vascular Accident OR Cerebrovascular Stroke |
| #6 | #4 OR #5 |
| #7 | upper limb[MeSH Terms] |
| #8 | upper limb movement dysfunction OR upper extremity motor dysfunction OR upper extremity movement dysfunction OR upper limb motor impairment |
| #9 | #7 OR #8 |
| #10 | randomized controlled trial[MeSH Terms] |
| #11 | randomized controlled study OR randomized clinical trial OR controlled clinical Trial |
| #12 | #10 OR #11 |
| #13 | #3 AND #6 AND #9 AND #12 |
Table 1 Strategy for searching eligible systematic reviews included in PubMed database
| 步骤 | 检索式 |
|---|---|
| #1 | Transcranial Magnetic Stimulation[MeSH Terms] |
| #2 | Repetitive Transcranial Magnetic Stimulation* OR theta burst stimulation OR TMS OR TBS |
| #3 | #1 OR #2 |
| #4 | Stroke[MeSH Terms] |
| #5 | Cerebrovascular Accident OR Cerebrovascular Apoplexy OR Brain Vascular Accident OR Cerebrovascular Stroke |
| #6 | #4 OR #5 |
| #7 | upper limb[MeSH Terms] |
| #8 | upper limb movement dysfunction OR upper extremity motor dysfunction OR upper extremity movement dysfunction OR upper limb motor impairment |
| #9 | #7 OR #8 |
| #10 | randomized controlled trial[MeSH Terms] |
| #11 | randomized controlled study OR randomized clinical trial OR controlled clinical Trial |
| #12 | #10 OR #11 |
| #13 | #3 AND #6 AND #9 AND #12 |
| 第一作者 | 发表时间(年) | 样本量(试验组/对照组) | 年龄(岁) | 性别(男/女) | 偏瘫侧(右/左) | 干预措施 | 结局指标 | ||
|---|---|---|---|---|---|---|---|---|---|
| 试验组 | 对照组 | 试验组 | 对照组 | ||||||
| 肖长林[ | 2019 | 15/17 | 63.7±11.0 | 58.7±10.8 | 21/11 | 15/17 | HF-rTMS | 假刺激 | ①②③ |
| 梁绮婷[ | 2018 | 38/38a | 64.3±11.8 | 65.5±10.5 | 47/31 | — | HF-rTMS | 常规疗法 | ①③ |
| 周哲[ | 2020 | 30/28 | 59.7±10.4 | 61.8±11.4 | 41/17 | 28/30 | HF-rTMS | 假刺激 | ①②③ |
| 王玉琴[ | 2020 | 36/36 | 52.0±6.9 | 53.1±6.8 | 41/31 | 28/44 | LF-rTMS | 假刺激 | ①③④ |
| 刘阅[ | 2018 | 10/13 | 56.9±9.0 | 55.4±8.4 | 14/9 | 9/14 | LF-rTMS | 常规疗法 | ①②③ |
| 李冰洁[ | 2016 | 20/20 | 51.5±7.1 | 51.4±6.6 | 23/17 | 25/15 | LF-rTMS | 常规疗法 | ①③④ |
| GOTTLIEB[ | 2021 | 14/14 | 63.9±10.9 | 62.4±11.5 | 12/16 | 8/20 | LF-rTMS | 假刺激 | ①② |
| SENIÓW[ | 2012 | 20/20 | 63.5±8.9 | 63.4±9.2 | 26/14 | 23/17 | LF-rTMS | 假刺激 | ① |
| 汤昕未[ | 2018 | 8/8 | 53.8±10.8 | 55.6±14.6 | 14/2 | 14/2 | iTBS | 假刺激 | ①③ |
| CHEN[ | 2019 | 11/11 | 52.9±11.1 | 52.6±8.3 | 14/8 | 15/7 | iTBS | 假刺激 | ①② |
| CHEN[ | 2021 | 12/11 | 54.4±10.6 | 48.9±9.6 | 18/5 | 18/5 | iTBS | 假刺激 | ①② |
| CHEN[ | 2021 | 16/16 | 57.4±8.0 | 51.4±9.2 | 7/25 | 13/19 | iTBS | 假刺激 | ③④ |
| KUZU[ | 2021 | 7/6 | 61.3±9.8 | 65.3±4.6 | 8/5 | 8/5 | cTBS | 假刺激 | ①② |
| CHA[ | 2021 | 20/20 | 67.6±7.2 | 69.1±6.0 | 25/15 | — | HF-rTMS | LF-rTMS | ① |
| KONDO[ | 2017 | 71/32 | 62.3±12.5 | 60.0±14.2 | 73/30 | 47/56 | LF-rTMS | cTBS | ① |
| 孟祥民[ | 2016 | 14/17/14b | 57.4±13.3/55.1±12.9 | 51.2±14.1 | 33/12 | 30/15 | HF-rTMS、LF-rTMS | 假刺激 | ①④ |
| LI[ | 2016 | 43/42/42b | 54.0±13.4/57.9±12.9 | 53.1±13.7 | 87/40 | 59/68 | HF-rTMS、LF-rTMS | 假刺激 | ①④ |
Table 2 Characteristics of the included studies
| 第一作者 | 发表时间(年) | 样本量(试验组/对照组) | 年龄(岁) | 性别(男/女) | 偏瘫侧(右/左) | 干预措施 | 结局指标 | ||
|---|---|---|---|---|---|---|---|---|---|
| 试验组 | 对照组 | 试验组 | 对照组 | ||||||
| 肖长林[ | 2019 | 15/17 | 63.7±11.0 | 58.7±10.8 | 21/11 | 15/17 | HF-rTMS | 假刺激 | ①②③ |
| 梁绮婷[ | 2018 | 38/38a | 64.3±11.8 | 65.5±10.5 | 47/31 | — | HF-rTMS | 常规疗法 | ①③ |
| 周哲[ | 2020 | 30/28 | 59.7±10.4 | 61.8±11.4 | 41/17 | 28/30 | HF-rTMS | 假刺激 | ①②③ |
| 王玉琴[ | 2020 | 36/36 | 52.0±6.9 | 53.1±6.8 | 41/31 | 28/44 | LF-rTMS | 假刺激 | ①③④ |
| 刘阅[ | 2018 | 10/13 | 56.9±9.0 | 55.4±8.4 | 14/9 | 9/14 | LF-rTMS | 常规疗法 | ①②③ |
| 李冰洁[ | 2016 | 20/20 | 51.5±7.1 | 51.4±6.6 | 23/17 | 25/15 | LF-rTMS | 常规疗法 | ①③④ |
| GOTTLIEB[ | 2021 | 14/14 | 63.9±10.9 | 62.4±11.5 | 12/16 | 8/20 | LF-rTMS | 假刺激 | ①② |
| SENIÓW[ | 2012 | 20/20 | 63.5±8.9 | 63.4±9.2 | 26/14 | 23/17 | LF-rTMS | 假刺激 | ① |
| 汤昕未[ | 2018 | 8/8 | 53.8±10.8 | 55.6±14.6 | 14/2 | 14/2 | iTBS | 假刺激 | ①③ |
| CHEN[ | 2019 | 11/11 | 52.9±11.1 | 52.6±8.3 | 14/8 | 15/7 | iTBS | 假刺激 | ①② |
| CHEN[ | 2021 | 12/11 | 54.4±10.6 | 48.9±9.6 | 18/5 | 18/5 | iTBS | 假刺激 | ①② |
| CHEN[ | 2021 | 16/16 | 57.4±8.0 | 51.4±9.2 | 7/25 | 13/19 | iTBS | 假刺激 | ③④ |
| KUZU[ | 2021 | 7/6 | 61.3±9.8 | 65.3±4.6 | 8/5 | 8/5 | cTBS | 假刺激 | ①② |
| CHA[ | 2021 | 20/20 | 67.6±7.2 | 69.1±6.0 | 25/15 | — | HF-rTMS | LF-rTMS | ① |
| KONDO[ | 2017 | 71/32 | 62.3±12.5 | 60.0±14.2 | 73/30 | 47/56 | LF-rTMS | cTBS | ① |
| 孟祥民[ | 2016 | 14/17/14b | 57.4±13.3/55.1±12.9 | 51.2±14.1 | 33/12 | 30/15 | HF-rTMS、LF-rTMS | 假刺激 | ①④ |
| LI[ | 2016 | 43/42/42b | 54.0±13.4/57.9±12.9 | 53.1±13.7 | 87/40 | 59/68 | HF-rTMS、LF-rTMS | 假刺激 | ①④ |
| 第一作者 | 刺激频率(Hz) | 刺激强度 | 总脉冲数 | 刺激部位 | 线圈类型 | 治疗方案及持续时间 |
|---|---|---|---|---|---|---|
| 肖长林[ | 10 | 90% RMT | 900 | 患侧C3、C4 | "8"字形线圈 | 9 min/次,5次/周,持续2周 |
| 梁绮婷[ | 3 | 90%~120% AMT | 900 | 患侧C3、C4 | "8"字形线圈 | 20 min/次,持续治疗2周后休息2 d,持续8周 |
| 周哲[ | 5 | 80% RMT | 1 200 | 患侧M1 | "8"字形线圈 | 5 min/次,5次/周,持续3周 |
| 王玉琴[ | 1 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续4周 |
| 刘阅[ | 1 | 90% AMT | 1 200 | 健侧M1 | "8"字形线圈 | 24 min/次,5次/周,持续8周 |
| 李冰洁[ | 1 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续2周 |
| GOTTLIEB[ | 1 | 100% RMT | 1 200 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续2周 |
| SENIÓW[ | 1 | 90% RMT | 1 200 | 健侧M1 | "8"字形线圈 | 30 min/次,5次/周,持续3周 |
| 汤昕未[ | 50-5 | 70% RMT | 600 | 患侧M1 | 圆形线圈 | 200 s/次,5次/周,持续2周 |
| CHEN[ | 50-5 | 80% AMT | 600 | 患侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
| CHEN[ | 50-5 | 80% AMT | 1 200 | 健侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续3周 |
| CHEN[ | 50-5 | 80% AMT | 600 | 患侧小脑 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
| KUZU[ | 50-5 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
| CHA[ | 10/1 | 90% RMT | 1 350/1 000 | 患侧M1/健侧M1 | "8"字形线圈 | 20 min/次,5次/周,持续2周 |
| KONDO[ | 1/50-5 | 90% RMT/80% AMT | 2 400 | 运动皮质 | "8"字形线圈 | 20 min/次,6次/周,共2周;160 s/次,6次/周,共2周 |
| 孟祥民[ | 10/1 | 80% AMT | 1 350/1 000 | 健侧M1/患侧M1 | 圆形线圈 | 20 min/次,5次/周,持续2周 |
| LI[ | 10/1 | 80% AMT | 1 350/1 000 | 健侧M1/患侧M1 | 圆形线圈 | 20 min/次,5次/周,持续2周 |
Table 3 rTMS parameters and treatment regimens in the included studies
| 第一作者 | 刺激频率(Hz) | 刺激强度 | 总脉冲数 | 刺激部位 | 线圈类型 | 治疗方案及持续时间 |
|---|---|---|---|---|---|---|
| 肖长林[ | 10 | 90% RMT | 900 | 患侧C3、C4 | "8"字形线圈 | 9 min/次,5次/周,持续2周 |
| 梁绮婷[ | 3 | 90%~120% AMT | 900 | 患侧C3、C4 | "8"字形线圈 | 20 min/次,持续治疗2周后休息2 d,持续8周 |
| 周哲[ | 5 | 80% RMT | 1 200 | 患侧M1 | "8"字形线圈 | 5 min/次,5次/周,持续3周 |
| 王玉琴[ | 1 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续4周 |
| 刘阅[ | 1 | 90% AMT | 1 200 | 健侧M1 | "8"字形线圈 | 24 min/次,5次/周,持续8周 |
| 李冰洁[ | 1 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续2周 |
| GOTTLIEB[ | 1 | 100% RMT | 1 200 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续2周 |
| SENIÓW[ | 1 | 90% RMT | 1 200 | 健侧M1 | "8"字形线圈 | 30 min/次,5次/周,持续3周 |
| 汤昕未[ | 50-5 | 70% RMT | 600 | 患侧M1 | 圆形线圈 | 200 s/次,5次/周,持续2周 |
| CHEN[ | 50-5 | 80% AMT | 600 | 患侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
| CHEN[ | 50-5 | 80% AMT | 1 200 | 健侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续3周 |
| CHEN[ | 50-5 | 80% AMT | 600 | 患侧小脑 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
| KUZU[ | 50-5 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
| CHA[ | 10/1 | 90% RMT | 1 350/1 000 | 患侧M1/健侧M1 | "8"字形线圈 | 20 min/次,5次/周,持续2周 |
| KONDO[ | 1/50-5 | 90% RMT/80% AMT | 2 400 | 运动皮质 | "8"字形线圈 | 20 min/次,6次/周,共2周;160 s/次,6次/周,共2周 |
| 孟祥民[ | 10/1 | 80% AMT | 1 350/1 000 | 健侧M1/患侧M1 | 圆形线圈 | 20 min/次,5次/周,持续2周 |
| LI[ | 10/1 | 80% AMT | 1 350/1 000 | 健侧M1/患侧M1 | 圆形线圈 | 20 min/次,5次/周,持续2周 |
| 第一作者 | 随机方法 | 盲法 | 分配隐藏 | 结果数据的完整性 | 选择性报告研究结果 | 其他偏倚来源 |
|---|---|---|---|---|---|---|
| 肖长林[ | 随机数字表 | 单盲 | 不清楚 | 有失访 | 否 | 不清楚 |
| 梁绮婷[ | 计算机随机 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
| 周哲[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| 王玉琴[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| 刘阅[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| 李冰洁[ | 随机数字表 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
| GOTTLIEB[ | 计算机随机 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
| SENIÓW[ | 计算机随机 | 双盲 | 不清楚 | 意向性分析 | 否 | 不清楚 |
| 汤昕未[ | 计算机随机 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| CHEN[ | 计算机随机 | 单盲 | 有 | 无失访 | 否 | 不清楚 |
| CHEN[ | 计算机随机 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
| CHEN[ | 随机数字表 | 双盲 | 不清楚 | 意向性分析 | 否 | 不清楚 |
| KUZU[ | 计算机随机 | 双盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| CHA[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| KONDO[ | 不清楚 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
| 孟祥民[ | 随机数字表 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
| LI[ | 随机数字表 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
Table 4 Risk of bias of the included studies
| 第一作者 | 随机方法 | 盲法 | 分配隐藏 | 结果数据的完整性 | 选择性报告研究结果 | 其他偏倚来源 |
|---|---|---|---|---|---|---|
| 肖长林[ | 随机数字表 | 单盲 | 不清楚 | 有失访 | 否 | 不清楚 |
| 梁绮婷[ | 计算机随机 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
| 周哲[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| 王玉琴[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| 刘阅[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| 李冰洁[ | 随机数字表 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
| GOTTLIEB[ | 计算机随机 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
| SENIÓW[ | 计算机随机 | 双盲 | 不清楚 | 意向性分析 | 否 | 不清楚 |
| 汤昕未[ | 计算机随机 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| CHEN[ | 计算机随机 | 单盲 | 有 | 无失访 | 否 | 不清楚 |
| CHEN[ | 计算机随机 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
| CHEN[ | 随机数字表 | 双盲 | 不清楚 | 意向性分析 | 否 | 不清楚 |
| KUZU[ | 计算机随机 | 双盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| CHA[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
| KONDO[ | 不清楚 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
| 孟祥民[ | 随机数字表 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
| LI[ | 随机数字表 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
| 干预方案 | HF-rTMS | LF-rTMS | iTBS | cTBS | 假刺激 |
|---|---|---|---|---|---|
| LF-rTMS | -0.06(-0.37,0.24) | — | — | — | — |
| iTBS | 0.24(-0.39,0.86) | 0.30(-0.31,0.92) | — | — | — |
| cTBS | -0.06(-0.63,0.52) | 0.00(-0.50,0.51) | -0.30(-1.07,0.48) | — | — |
| 假刺激 | 0.47(0.17,0.78)a | 0.54(0.26,0.82)a | 0.24(-0.31,0.78) | 0.53(-0.02,1.09) | — |
| 常规疗法 | 0.66(0.21,1.10)a | 0.72(0.28,1.16)a | 0.42(-0.31,1.15) | 0.71(0.05,1.37)a | 0.18(-0.30,0.67) |
Table 5 Network meta-analysis of different modalities of rTMS intervention in increasing the FMA-UE score for stroke patients with upper limb motor dysfunction
| 干预方案 | HF-rTMS | LF-rTMS | iTBS | cTBS | 假刺激 |
|---|---|---|---|---|---|
| LF-rTMS | -0.06(-0.37,0.24) | — | — | — | — |
| iTBS | 0.24(-0.39,0.86) | 0.30(-0.31,0.92) | — | — | — |
| cTBS | -0.06(-0.63,0.52) | 0.00(-0.50,0.51) | -0.30(-1.07,0.48) | — | — |
| 假刺激 | 0.47(0.17,0.78)a | 0.54(0.26,0.82)a | 0.24(-0.31,0.78) | 0.53(-0.02,1.09) | — |
| 常规疗法 | 0.66(0.21,1.10)a | 0.72(0.28,1.16)a | 0.42(-0.31,1.15) | 0.71(0.05,1.37)a | 0.18(-0.30,0.67) |
| 干预方案 | FMA-UE | MAS | MBI/BI | MEP潜伏期 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | |
| HF-rTMS | 71.1 | 20.1 | 2.4 | 38.0 | 2.6 | 4.1 | 38.6 | 0 | 3.5 | 80.0 | 43.8 | 1.8 |
| LF-rTMS | 79.9 | 29.2 | 2.0 | 64.1 | 14.7 | 2.8 | 96.4 | 85.6 | 1.1 | 78.9 | 33.2 | 1.8 |
| iTBS | 45.8 | 9.8 | 3.7 | 77.0 | 45.5 | 2.1 | 74.9 | 14.4 | 2.0 | 24.9 | 2.1 | 4.0 |
| cTBS | 75.3 | 40.9 | 2.2 | 61.0 | 31.0 | 2.9 | — | — | — | — | — | — |
| 假刺激 | 20.2 | 0 | 5.0 | 30.6 | 0.2 | 4.5 | 30.7 | 0 | 3.8 | 7.5 | 0 | 4.7 |
| 常规疗法 | 7.7 | 0 | 5.6 | 29.2 | 6.1 | 4.5 | 9.4 | 0 | 4.6 | 58.8 | 20.9 | 2.7 |
Table 6 SUCRA probabilities for the effectiveness of different modalities of rTMS intervention in stroke patients with upper limb motor dysfunction
| 干预方案 | FMA-UE | MAS | MBI/BI | MEP潜伏期 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | |
| HF-rTMS | 71.1 | 20.1 | 2.4 | 38.0 | 2.6 | 4.1 | 38.6 | 0 | 3.5 | 80.0 | 43.8 | 1.8 |
| LF-rTMS | 79.9 | 29.2 | 2.0 | 64.1 | 14.7 | 2.8 | 96.4 | 85.6 | 1.1 | 78.9 | 33.2 | 1.8 |
| iTBS | 45.8 | 9.8 | 3.7 | 77.0 | 45.5 | 2.1 | 74.9 | 14.4 | 2.0 | 24.9 | 2.1 | 4.0 |
| cTBS | 75.3 | 40.9 | 2.2 | 61.0 | 31.0 | 2.9 | — | — | — | — | — | — |
| 假刺激 | 20.2 | 0 | 5.0 | 30.6 | 0.2 | 4.5 | 30.7 | 0 | 3.8 | 7.5 | 0 | 4.7 |
| 常规疗法 | 7.7 | 0 | 5.6 | 29.2 | 6.1 | 4.5 | 9.4 | 0 | 4.6 | 58.8 | 20.9 | 2.7 |
| 干预方案 | HF-rTMS | LF-rTMS | iTBS | cTBS | 假刺激 |
|---|---|---|---|---|---|
| LF-rTMS | -0.24(-0.94,0.45) | — | — | — | — |
| iTBS | -0.50(-1.43,0.44) | -0.25(-1.26,0.75) | — | — | — |
| cTBS | -0.28(-1.46,0.89) | -0.04(-1.28,1.20) | 0.21(-1.17,1.60) | — | — |
| 假刺激 | 0.05(-0.37,0.46) | 0.29(-0.27,0.85) | 0.54(-0.29,1.38) | 0.33(-0.77,1.43) | — |
| 常规疗法 | 0.14(-0.94,1.23) | 0.39(-0.45,1.22) | 0.64(-0.67,1.95) | 0.43(-1.06,1.92) | 0.10(-0.91,1.10) |
Table 7 Network meta-analysis of different rTMS intervention modalities in decreasing the MAS score in stroke patients with upper limb motor dysfunction
| 干预方案 | HF-rTMS | LF-rTMS | iTBS | cTBS | 假刺激 |
|---|---|---|---|---|---|
| LF-rTMS | -0.24(-0.94,0.45) | — | — | — | — |
| iTBS | -0.50(-1.43,0.44) | -0.25(-1.26,0.75) | — | — | — |
| cTBS | -0.28(-1.46,0.89) | -0.04(-1.28,1.20) | 0.21(-1.17,1.60) | — | — |
| 假刺激 | 0.05(-0.37,0.46) | 0.29(-0.27,0.85) | 0.54(-0.29,1.38) | 0.33(-0.77,1.43) | — |
| 常规疗法 | 0.14(-0.94,1.23) | 0.39(-0.45,1.22) | 0.64(-0.67,1.95) | 0.43(-1.06,1.92) | 0.10(-0.91,1.10) |
| 干预方案 | HF-rTMS | LF-rTMS | iTBS | 假刺激 |
|---|---|---|---|---|
| LF-rTMS | -0.87(-1.34,-0.39) | — | — | — |
| iTBS | -0.48(-1.17,0.20) | 0.38(-0.33,1.10) | — | — |
| 假刺激 | 0.04(-0.33,0.41) | 0.91(0.49,1.33)a | 0.53(-0.05,1.10) | — |
| 常规疗法 | 0.23(-0.16,0.63) | 1.10(0.66,1.54)a | 0.72(-0.03,1.46) | 0.19(-0.28,0.66) |
Table 8 Network meta-analysis of different modalities of rTMS intervention in increasing the MBI and BI scores in stroke patients with upper limb motor dysfunction
| 干预方案 | HF-rTMS | LF-rTMS | iTBS | 假刺激 |
|---|---|---|---|---|
| LF-rTMS | -0.87(-1.34,-0.39) | — | — | — |
| iTBS | -0.48(-1.17,0.20) | 0.38(-0.33,1.10) | — | — |
| 假刺激 | 0.04(-0.33,0.41) | 0.91(0.49,1.33)a | 0.53(-0.05,1.10) | — |
| 常规疗法 | 0.23(-0.16,0.63) | 1.10(0.66,1.54)a | 0.72(-0.03,1.46) | 0.19(-0.28,0.66) |
| 干预方案 | HF-rTMS | LF-rTMS | iTBS | 假刺激 |
|---|---|---|---|---|
| LF-rTMS | 0.02(-0.34,0.37) | — | — | — |
| iTBS | 0.69(-0.10,1.48) | 0.68(-0.09,1.44) | — | — |
| 假刺激 | 0.91(0.55,1.28)a | 0.90(0.59,1.20)a | 0.22(-0.48,0.92) | — |
| 常规疗法 | 0.22(-0.51,0.94) | 0.20(-0.43,0.83) | -0.48(-1.47,0.52) | -0.70(-1.40,0) |
Table 9 Network meta-analysis of different rTMS intervention modalities in reducing the MEP latency in stroke patients with upper limb motor dysfunction
| 干预方案 | HF-rTMS | LF-rTMS | iTBS | 假刺激 |
|---|---|---|---|---|
| LF-rTMS | 0.02(-0.34,0.37) | — | — | — |
| iTBS | 0.69(-0.10,1.48) | 0.68(-0.09,1.44) | — | — |
| 假刺激 | 0.91(0.55,1.28)a | 0.90(0.59,1.20)a | 0.22(-0.48,0.92) | — |
| 常规疗法 | 0.22(-0.51,0.94) | 0.20(-0.43,0.83) | -0.48(-1.47,0.52) | -0.70(-1.40,0) |
Figure 7 Corrected funnel plots for different rTMS intervention modalities in increasing the FMA-UE score in stroke patients with upper limb motor dysfunction
| [1] |
孙海欣,王文志. 我国脑卒中流行状况及其防控策略[J]. 中华神经科杂志,2017,50(12):881-884. DOI:10.3760/cma.j.issn.1006-7876.2017.12.001.
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] | |
| [6] |
|
| [7] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国各类主要脑血管病诊断要点2019[J]. 中华神经科杂志,2019,52(9):710-715. DOI:10.3760/cma.j.issn.1006-7876.2019.09.003.
|
| [8] |
李静,李幼平. 不断完善与发展的Cochrane系统评价[J]. 中国循证医学杂志,2008,8(9):742-743.
|
| [9] |
肖长林,潘翠环,陈艳,等. 不同频率高频重复经颅磁刺激对缺血性脑卒中患者上肢功能的效果[J]. 中国康复理论与实践,2019,25(5):557-563. DOI:10.3969/j.issn.1006-9771.2019.05.011.
|
| [10] |
梁绮婷,钟燕桃,施晓耕,等. 高频重复经颅磁刺激对脑卒中患者上肢运动及感觉功能的影响[J]. 中华老年心脑血管病杂志,2018,20(11):1187-1190. DOI:10.3969/j.issn.1009-0126.2018.11.016.
|
| [11] |
周哲,沈夏锋,熊莉,等. 运动前区高频重复经颅磁刺激对脑卒中上肢功能康复的疗效[J]. 中国康复理论与实践,2020,26(6):697-702. DOI:10.3969/j.issn.1006-9771.2020.06.014.
|
| [12] |
王玉琴,吕铭新,刘双洁,等. 高剂量低频健侧重复经颅磁刺激对脑梗死后上肢运动功能的影响[J]. 中国生物医学工程学报,2020,39(4):508-512. DOI:10.3969/j.issn.0258-8021.2020.04.015.
|
| [13] |
刘阅,王晓阳,张长龙,等. 低频重复经颅磁刺激改善脑卒中后上肢痉挛的任务态功能磁共振研究[J]. 中国康复理论与实践,2018,24(7):828-833. DOI:10.3969/j.issn.1006-9771.2018.07.014.
|
| [14] |
李冰洁,李芳,张通. 不同强度低频重复经颅磁刺激对脑卒中后上肢运动功能障碍的疗效[J]. 中国康复理论与实践,2016,22(9):1004-1007.
|
| [15] |
|
| [16] |
|
| [17] |
汤昕未,胡瑞萍,朱玉连,等. 间歇性θ短阵脉冲刺激对脑卒中后运动功能障碍的影响[J]. 中国康复医学杂志,2018,33(12):1410-1415. DOI:10.3969/j.issn.1001-1242.2018.12.006.
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
孟祥民,赵宇阳,杨传美,等. 重复经颅磁刺激对脑梗死患者上肢运动功能的影响[J]. 中国康复医学杂志,2016,31(6):664-669. DOI:10.3969/j.issn.1001-1242.2016.06.010.
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
陈娟,林慈宽,程丽芳. 低频rTMS刺激联合早期康复运动对缺血性脑卒中患者运动、语言功能恢复的影响[J]. 海南医学,2021,32(15):1922-1925. DOI:10.3969/j.issn.1003-6350.2021.15.005.
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [1] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [2] | LIU Ying, LIU Shiwei, ZHANG Chi, SHEN Ji, ZHANG Yushan, ZHANG Jie, SANG Yingchen, WANG Youjiao, WANG Lei, ZHOU Houguang, SHI Hong. Prevalence and Associated Factors of Subjective Cognitive Decline among Older Stroke Patients in China [J]. Chinese General Practice, 2026, 29(20): 2829-2835. |
| [3] | LI Yutong, ZHAO Danting, JIANG Feng, WANG Yanna, LIU Yizong, LIANG Wenjuan, LU Jiahai. Systematic Review and Meta-analysis of the Efficacy and Safety of mRNA and Recombinant Protein Subunit Vaccines Against Respiratory Syncytial Virus [J]. Chinese General Practice, 2026, 29(19): 2744-2752. |
| [4] | WU Ruining, ZHOU Ming, ZHANG Gongzi, LI Jun, XIE Suhang, LIU Yangxiaoxue, ZHANG Jiali, LIU Maomao, HUANG Liping. Study on Fixed and Mobile Exoskeleton Robots in Improving Lower Limb Function and Quality of Life in Stroke Patients: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(17): 2326-2333. |
| [5] | JI Ying, GUO Chuan, ZHU Shizhe, JI Panpan, WANG Tong, KAN Chaojie, WANG Qinglei. Effects of Intermittent Theta Burst Stimulation of the Cerebellum on Different Balance Abilities in Patients with Supratentorial Stroke: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(15): 2022-2028. |
| [6] | TIAN Anni, YANG Jing, SUN Jing, WANG Shichun. Effect of Robot-assisted Training on the Recovery of Hand Motor Function in Patients with Different Stages of Stroke: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1911-1920. |
| [7] | HAN Yue, BIAN Zhe, GU Haochen, WANG Dali, PENG Yanbo. Impact of Cumulative Defined Daily Dose of Statins on Recurrence Risk in Ischemic Stroke Patients [J]. Chinese General Practice, 2026, 29(14): 1821-1826. |
| [8] | LIU Yang, LIANG Fang, WU Ling, LI Wenlei, LI Pengfei. Diagnostic Value of Non-conventional Lipids and the Triglyceride-glucose Index in First-onset Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(11): 1422-1429. |
| [9] | WANG Fei, HAN Weiyu, SUN Tao. Moxibustion Combined with Three-step Therapy in the Treatment of Cancer Pain: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(09): 1203-1211. |
| [10] | WANG Xiaonan, RUAN Xiaonan, LIU Yang, WU Kang, QIU Hua, LIU Qingping, SONG Jiahui, GAO Jiaojiao, ZHOU Yi, LIU Xiaolin. Correlation between Anthropometric Indices and the Risk of Stroke: a Nested Case-control Study [J]. Chinese General Practice, 2026, 29(08): 1020-1028. |
| [11] | CAO Lei, LIU Xuechun, JIANG Wei, CHEN Yan, YAN Sunhong, DU Jing. Study on the Prediction of Muscle Attenuation in Patients with Acute Ischemic Stroke by the Cross-sectional Area and Thickness of the Temporalis Muscle [J]. Chinese General Practice, 2026, 29(08): 997-1007. |
| [12] | ZHANG Ling, HUANG Shuangying, XU Hui, MEI Huiting, HONG Yongping. Effects of Different Exercise Types on Fall Efficacy in the Elderly: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(06): 741-751. |
| [13] | HU Naixiao, ZHANG Hao, WANG Bo, QI Xin, DONG Jianhong, XUE Ruizhong, ZHANG Qingsu. Study of the Therapeutic Effect of Intraoral Balloon Dilation Combined with K-point Stimulation in Patients with Post-stroke Pseudobulbar Palsy Associated Dysphagia and Trismus [J]. Chinese General Practice, 2026, 29(05): 591-596. |
| [14] | ZHAO Xuejiao, LI Juan, LI Yujie, LU Ting, Xian Lihong, YAN Huan. Prevalence Trends and Influencing Factors for Post-stroke Cognitive Impairment in China: a Meta-analysis [J]. Chinese General Practice, 2026, 29(03): 380-392. |
| [15] | FAN Zhuanzhuan, LI Wenting, MA Guoliang. Relationship between the Chinese Visceral Adipose Index and Cardiovascular Disease in Postmenopausal Women: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(02): 180-187. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||